PDSB - PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q3 2021 Results - Earnings Call Transcript

PDS Biotechnology Corporation (PDSB) Q3 2021 Results Conference Call November 10, 2021 08:00 AM ET Company Participants Deanne Randolph - Vice President of Commercial Development Frank Bedu-Addo - Chief Executive Officer Matthew Hill - Chief Financial Officer Lauren Wood - Chief Medical Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Leland Gershell - Oppenheimer Emanuela Branchetti - H. C. Wainwright Presentation Operator Greetings and welcome to PDS Biotechnology’s Third Quarter 2021 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] please note, this conference is being recorded. At this time, I would now turn the conference over to, Deanne Randolph, Vice President of Commercial Development. Deanne, you may now begin. Deanne Randolph Good morning, and welcome to PDS Biotechnology’s third quarter 2021 earnings conference call and audio webcast. With me today are Dr.

For further details see:

PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q3 2021 Results - Earnings Call Transcript